University of California San Francisco
Give to UCSF
‘Hidden Biological Link’ Among Autism Genes Revealed in Study
A new study of autism risk genes by UCSF and UC Berkeley scientists implicates disruption in prenatal neurogenesis – a process in which specialized “progenitor” cells give rise to new brain cells – in the development of autism spectrum disorders.
UCSF, Gladstone Launch Center for Neurovascular Brain Immunology
The new center will provide an integrated platform for basic and clinical research, bringing together vascular biology, immunology, and neuroscience.
Minority Patients Miss Out On Life-Saving Cystic Fibrosis Drugs Due to Genetic Test Limitations
A new study shows how minority patients are effectively disqualified from receiving the latest cystic fibrosis drugs approved only for people with mutations more common among white patients.
UCSF Partnership With San Francisco Brings COVID-19 Vaccinations to the Mission District
The vaccination site builds off previous work with Unidos en Salud to bring COVID-19 testing to the Mission District.
Could this Llama-Inspired Nanobody Help Curtail COVID?
A UCSF team has engineered a tiny antibody capable of neutralizing the coronavirus.
UCSF Expands Vaccination Effort in Partnership with City of San Francisco
As its supply of COVID-19 vaccines increases, UC San Francisco is expanding its vaccination efforts to those most at risk – the elderly and health care workers in the community
COVID-19 Vaccine Fact Vs. Fiction: An Expert Weighs in on Common Fears
We posed the most common COVID-19 vaccine quandaries to Bryn Boslett, MD, an infectious disease expert who is leading the vaccination effort at UCSF. She explains why mRNA vaccines won’t affect your DNA, which allergies pose a risk, what 95 percent efficacy really means, and more.
Alcohol Causes Immediate Effects Linked to Heart Malady
UCSF researchers found that alcohol has an immediate effect on the heart in patients with atrial fibrillation, the most common life-threatening heart-rhythm disorder.
Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including B.1.1.7 Variant
In two preclinical models of COVID-19, plitidepsin showed a 100-fold reduction in viral replication in the lungs and demonstrated an ability to reduce lung inflammation.
